title: New treatments for cystic fibrosis.
abstract: The cornerstones of CF medical treatment remain optimised nutrition, antibiotics and chest physiotherapy. There are however a number of promising new approaches which may add considerably to these traditional treatments. The most fundamental prospective new treatment is gene therapy which is still a long way off but could, in theory, provide a virtual cure for the disease. Less visionary but potentially as important is drug therapy aimed at the basic defect in airway ion transport. Both of these approaches are best suited to patients with early or even pre-symptomatic disease. In contrast, a third group of new treatments may prove useful in patients with established lung damage; these include a variety of anti-inflammatory drugs and DNase. This chapter will discuss each of these new treatments as well as exploring the difficult issue of assessing new treatments in pre-symptomatic disease.
authors.affiliation: Royal Brompton & St Mary's Hospital Medical School, London, UK.
authors.forename: E
authors.initials: E
authors.lastname: Alton
authors.forename: N
authors.initials: N
authors.lastname: Caplen
authors.forename: D
authors.initials: D
authors.lastname: Geddes
authors.forename: R
authors.initials: R
authors.lastname: Williamson
mesh_terms: D000584:Amiloride / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002712:Chlorides / Q000378:metabolism; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000628:therapy*; D003851:Deoxyribonucleases / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D012964:Sodium / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D002712:Chlorides; D000584:Amiloride; D012964:Sodium; D003851:Deoxyribonucleases